All

Enterome announces presentation of data from ongoing Phase 1/2 trial of its peptide-based immunotherapy EO2401 in recurrent glioblastoma (ROSALIE study) at SNO 2022
16 November 2022

Enterome announces presentation of data from ongoing Phase 1/2 trial of its peptide-based immunotherapy EO2401 in recurrent glioblastoma (ROSALIE study) at SNO 2022

Enterome announces it will present updated efficacy, immunogenicity and safety data from its Phase 1/2 trial of EO2401 in combination with nivolumab +/- bevacizumab, in...

Read the press release
SITC oral presentation yesterday by Dr Reardon / update on EO2401 ROSALIE study in rGBM
11 November 2022

SITC oral presentation yesterday by Dr Reardon / update on EO2401 ROSALIE study in rGBM

Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, today announces...

Read the press release
MaaT Pharma Announces Participation in Scientific and Investor Conferences in November
7 November 2022

MaaT Pharma Announces Participation in Scientific and Investor Conferences in November

MaaT Pharma, a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients...

Read the press release
Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field.
17 October 2022

Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field.

Clinical Microbiomics, a pioneering microbiome research
company, today announced its acquisition of MS-Omics, a leading metabolomics provider
based in Denmark.

Read the press release
Clinical Microbiomics set to accelerate its expansion with EUR 10 million investment from Health for Life Capital™ II” managed by Seventure Partners
11 October 2022

Clinical Microbiomics set to accelerate its expansion with EUR 10 million investment from Health for Life Capital™ II” managed by Seventure Partners

Seventure Partners, a worldwide leading microbiome venture capital, and Clinical Microbiomics A/S, a pioneering microbiome research company, today announced the completion of a...

Read the press release
Foodtech startup STANDING OVATION closes a €12M Series A financing round to accelerate the development of its animal-free casein and cheese substitute production process
14 September 2022

Foodtech startup STANDING OVATION closes a €12M Series A financing round to accelerate the development of its animal-free casein and cheese substitute production process

STANDING OVATION, a player in the food transition, announced today a Series A financing round of €12 million led by Astanor Ventures, with the participation of Peakbridge,...

Read the press release
Top VC Funds In France To Finance Your Startup
7 September 2022

Top VC Funds In France To Finance Your Startup

According to PitchBook data, France is Europe's second-largest VC hub by the amount of capital invested. The ecosystem is growing and expanding year by year, as it shows, in...

Read more
SumUp launches Magic Pay for the hospitality sector
21 July 2022

SumUp launches Magic Pay for the hospitality sector

SumUp, the financial partner for over 4 million small businesses worldwide, today announced the launch of SumUp Magic Pay, a QR code payment solution for the hospitality...

Read more
Launchmetrics launches visual content platform and invests in AI
20 July 2022

Launchmetrics launches visual content platform and invests in AI

Launchmetrics' expansion into the visual content sector began in 2019 with the acquisition of Italian company IMAXtree. The deal underscored the company's interest in...

Read more
Siolta Therapeutics Announces First Newborn Dosed in Their Phase 2 ADORED Study Evaluating a Potential First-In-Class Live Biotherapeutic Product for the Prevention of Atopic Diseases
20 July 2022

Siolta Therapeutics Announces First Newborn Dosed in Their Phase 2 ADORED Study Evaluating a Potential First-In-Class Live Biotherapeutic Product for the Prevention of Atopic Diseases

Siolta Therapeutics, a clinical-stage biopharmaceutical company developing novel targeted live biotherapeutic products (LBPs) to prevent and treat diseases of high unmet...

Read more